Telescope Innovations to Deliver First Self-Driving Lab for Korea's Largest Biopharma Manufacturers Association

Executive Summary

• Telescope Innovations announced that Korea’s largest biopharma association (KPBMA) has purchased and will install one of its Self‑Driving Lab (SDL) platforms at a new R&D facility in Seoul.
• The SDL deployment marks the first AI‑driven training hub for drug discovery in Korea and establishes a strategic partnership aimed at broader SDL adoption across Korean pharma and other industries.
• Telescope positions the deal as a gateway to accelerated pharmaceutical R&D in Asia and anticipates further regional deployments in agriculture, minerals, energy, and chemicals.

Key Details

• Customer: Korean Pharmaceutical and Biopharmaceutical Manufacturers Association (KPBMA).
• Product: One Self‑Driving Lab (SDL) platform – an automated system integrating robotics, inline analytics, and AI/machine‑learning for continuous closed‑loop experimentation.
• Installation Timeline: Installation to occur “in a matter of weeks” with commissioning shortly thereafter.
• Strategic Purpose: SDL will serve as the core of KPBMA’s Convergence AI Institute for Drug Discovery (CAIID) training hub, providing education, up‑skilling, and demonstration of automated R&D capabilities.
• Geographic Significance: First SDL deployment in South Korea; intended to catalyze broader adoption across Asian biopharma institutes and commercial labs.
• Commercial Outlook: Telescope highlights expanding relevance of SDLs beyond pharma into agriculture, minerals, energy, and chemicals, citing the platform’s suitability for remote or high‑risk environments.
• Leadership Comments:
• Junhee Pyo (CAIID Vice Chief) – emphasizes innovation impact on Korean drug development.
• Jason Hein (CTO, Telescope) – notes milestone for intelligent automation technology.
• Henry Dubina (CEO, Telescope) – stresses Asia’s rapid market growth for lab automation and the partnership’s role in regional expansion.

Notable Quotes

• “We anticipate that this Self‑Driving Lab will bring significant innovation to new drug development processes in Korea.” – Junhee Pyo, CAIID Vice Chief
• “Delivering our first Self‑Driving Lab in South Korea will mark a major milestone for Telescope's intelligent automation technology…” – Jason Hein, CTO, Telescope Innovations
• “Partnering with KPBMA on Korea's first AI‑driven SDL hub positions Telescope at the center of this momentum.” – Henry Dubina, CEO, Telescope Innovations